International archives of otorhinolaryngology · 2025
Effect of Topical Intra-Auricular Lidocaine on Tinnitus: A Randomized Double-Blind Placebo-Controlled Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Campos Tatiane Vacaro, Bento Ricardo Ferreira, Oticica Jeanne, Jabour Maíra Said, Távora Nathália, Jardim Isabela, de Marchi Cristiane Leite, Tsuji Robinson Koji
Аннотация
INTRODUCTION: Tinnitus is a prevalent symptom and has no proven effective treatment. Clinical observations that some patients reported significantly improved tinnitus after topical ear drop administration of lidocaine motivated research on this drug.
OBJECTIVE: Evaluate the action of topical intra-auricular 10% lidocaine in suppressing tinnitus compared to placebo.
METHODS: This was a randomized, crossover, double-blind, placebo-controlled clinical trial. The variations of the visual analog scale (VAS), tinnitus loudness, and the minimum masking level (MML) after intra-auricular lidocaine 10% were compared with a placebo. The same variables were compared with some sample features.
RESULTS: There was no statistically significant difference between the action of lidocaine and placebo in tinnitus variation measured by VAS (p = 0.361), tinnitus loudness (p = 0.850), and MML. (p = 0.213). The VAS variation was statistically lower in patients with any hearing loss (p = 0.005); the tinnitus loudness variation was higher in patients with tinnitus modulation (p = 0.049) and lower in patients with any hearing loss (p = 0.045). The MML variation was lower in patients with bruxism/TMD (p = 0.026).
CONCLUSION: In this study the action of lidocaine on the variation of tinnitus intensity was similar to placebo. We believe that the use of manipulated medication may have interfered in the outcome and that the large number of patients with positive response to placebo should be investigated in further studies.
OBJECTIVE: Evaluate the action of topical intra-auricular 10% lidocaine in suppressing tinnitus compared to placebo.
METHODS: This was a randomized, crossover, double-blind, placebo-controlled clinical trial. The variations of the visual analog scale (VAS), tinnitus loudness, and the minimum masking level (MML) after intra-auricular lidocaine 10% were compared with a placebo. The same variables were compared with some sample features.
RESULTS: There was no statistically significant difference between the action of lidocaine and placebo in tinnitus variation measured by VAS (p = 0.361), tinnitus loudness (p = 0.850), and MML. (p = 0.213). The VAS variation was statistically lower in patients with any hearing loss (p = 0.005); the tinnitus loudness variation was higher in patients with tinnitus modulation (p = 0.049) and lower in patients with any hearing loss (p = 0.045). The MML variation was lower in patients with bruxism/TMD (p = 0.026).
CONCLUSION: In this study the action of lidocaine on the variation of tinnitus intensity was similar to placebo. We believe that the use of manipulated medication may have interfered in the outcome and that the large number of patients with positive response to placebo should be investigated in further studies.